Well, DEW it appears the contract manufacturing situation was resolved. If there was an addendum to the approval wouldn't the FDA ackowledge it?
If I read the indication correctly it states it can be used as a monotherapy for patients who cannot tolerate irinotecan. Ahhh. The irony and those missing hospital records.